Perception of Healthcare Professionals Regarding Generic Drugs: Impact on their Prescription in Hospital Settings
Year: 2025
Type: article
Study design: Observational Study
Abstract: Introduction: Generic drugs have become increasingly prevalent in global healthcare systems, offering a cost-effective alternative to brand-name medications. Despite their documented benefits, the acceptance and utilization of generics remain contentious, particularly in hospital settings where prescriber confidence and patient adherence are crucial. In Morocco, the promotion of generics is integral to national healthcare policies aimed at improving access to affordable medications. However, their prescription and use remain relatively low compared to other countries, due to concerns regarding their effectiveness, safety, and therapeutic interchangeability. Objectives: This study aims to evaluate the perception of healthcare professionals regarding generic drugs in Morocco, analyze their impact on prescription practices in hospital settings, and identify factors influencing prescriber attitudes. The study also seeks to enhance understanding of generics' role in improving healthcare accessibility and reducing costs. Materials and Methods: A cross-sectional descriptive study was conducted between January 1 and January 30, 2025, among 94 licensed physicians practicing in both public and private sectors across Morocco. The study employed an anonymous, validated Google Forms questionnaire to assess the perception of generics and their influence on prescribing practices. Data were analyzed using Microsoft Excel. Results: The study revealed a significant reluctance among healthcare professionals toward prescribing generics, with 55% of physicians only recommending generics when bioequivalence is guaranteed. Despite 81% of physicians regularly recommending generics, 70% perceive them as sometimes less effective than brand-name drugs. A majority 55% expressed partial satisfaction with the available information on generics, highlighting the need for improved educational resources. The study also found that price was the primary factor influencing patients acceptance of generics, particularly among lower-income individuals. Conclusion: This study underscores the need for enhanced education and training on the bioequivalence, effectiveness, and safety of generics to improve prescriber confidence. Furthermore, increasing patient awareness and addressing economic factors are crucial for the wider adoption of generics. By fostering better understanding and communication about generics, both healthcare professionals and patients can benefit from reduced healthcare costs while maintaining therapeutic standards.
Institution: Mohammed V University
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
OpenAlex ID: W4411112320